Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06018857

Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation

This is a registry study examining patients with HCC undergoing liver transplantation including outcomes and predictors of recurrence

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Cleveland Clinic Foundation, Cleveland, Ohio, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients (age>18 years) undergoing Liver transplant for hepatocellular carcinoma

Exclusion criteria

  • Patients under 18 years old
  • Patients who do not have hepatocellular carcinoma
  • patients who have hepatocellular carcinoma but do not undergo liver transplantation

Treatment and study plan

Primary outcomes

  1. Recurrence Free Survival

    Time frame: From date of surgery to date of identified cancer recurrence through either clinical judgement or scans. This is assessed up to 10 years after the surgery.

  2. Overall Survival

    Time frame: From date of surgery to date of death, up to 10 years after the surgery.

Sponsors and collaborators

Lead sponsor

Federico Aucejo

Other

Collaborators

  • Ohio State University

Registry information

Important dates

Study start
2017
Primary completion
2028
Study completion
2028
First posted
Aug 31, 2023
Registry last updated
Mar 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.